3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Genitourinary
1
Dermatologic
1
Conditions
Breast Neoplasms
41
Melanoma
8
Uterine Cervical Neoplasms
7
Endometrial Neoplasms
7
Mouth Neoplasms
4
Carcinoma, Intraductal, Noninfiltrating
4
Vulvar Neoplasms
3
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Uterine Neoplasms
2
Rectal Neoplasms
2
Neoplasm Micrometastasis
2
Neoplasm Metastasis
2
Lymphatic Metastasis
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Head and Neck Neoplasms
2
Eccrine Porocarcinoma
2
Breast Neoplasms, Male
2
Breast Carcinoma In Situ
2
Waldenstrom Macroglobulinemia
1
Sentinel Lymph Node Biopsy (SLNB)
1
Sentinel Lymph Node
1
Sarcoidosis, Pulmonary
1
Sarcoidosis
1
Recurrence
1
Recurent Vulvar Carcinoma
1
Prostatic Neoplasms
1
Penile Neoplasms
1
Pediatric Patients With Solid Tumors
1
Pancreatic Neoplasms
1
Interventions
pembrolizumab
5
Paclitaxel
4
Ifosfamide
4
Cisplatin
4
Nivolumab
3
avelumab
2
aldesleukin
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
Adoptive Transfer
2
vinflunine
1
toripalimab
1
rocakinogene sifuplasmid
1
niraparib
1
nimotuzumab
1
lenvatinib
1
enfortumab vedotin
1
durvalumab
1
dostarlimab
1
dacomitinib
1
cemiplimab
1
cabazitaxel
1
Vorinostat
1
VGX-3100
1
Ultrasonography
1
Surveys and Questionnaires
1
Sildenafil Citrate
1
Sentinel Lymph Node Biopsy
1
Psychiatric Rehabilitation
1
Psychiatric Nursing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Penile Neoplasms
×
Sentinel Lymph Node Biopsy
×
Clear all
NCT06666634
2024-10-30
NANOSCAN
The Netherlands Cancer Institute
Phase NA
Recruiting
29 enrolled